Literature DB >> 16840339

Functional genomic analysis of herpes simplex virus type 1 counteraction of the host innate response.

Tracy Jo Pasieka1, Tracey Baas, Victoria S Carter, Sean C Proll, Michael G Katze, David A Leib.   

Abstract

Herpes simplex virus type 1 (HSV-1) mutants lacking the ICP34.5 gene are severely attenuated in mouse models and have a significant growth defect in confluent mouse embryo fibroblasts. Previously, ICP34.5 was demonstrated to have a crucial role in evading the innate immune response to infection by mediating the dephosphorylation of eIF2alpha, a translation initiation factor phosphorylated by PKR during the antiviral response. To further understand the role of ICP34.5 in evasion of the antiviral response, we used transcriptional profiling to examine host cell gene expression in both wild-type and ICP34.5-null virus-infected mouse embryo fibroblasts over a time course of infection. Our study revealed that cells responded to infection within 3 h through PKR-dependent eIF2alpha phosphorylation and that the majority of up-regulated genes at 3 h postinfection were involved in the antiviral response. HSV-1 counters this response through early expression of ICP34.5 and dephosphorylation of eIF2alpha. By 12 h postinfection, the differences between the number and functional classification of genes differentially up- and down-regulated between wild-type and ICP34.5-null virus-infected cells were maximal. Specifically, in wild-type virus-infected cells, the majority of changed genes were involved in metabolic and biosynthetic processes, while in ICP34.5-null virus-infected cells, mostly antiviral genes were up-regulated. Further, ICP34.5-null virus-infected cells produced greater amounts of beta interferon than wild-type virus-infected cells. These results indicate that ICP34.5 expression and function at early times postinfection have a pivotal role in the ability of HSV-1 to gain control of the host cell and maintain an environment for successful viral replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16840339      PMCID: PMC1563739          DOI: 10.1128/JVI.00333-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  61 in total

1.  Repression of host RNA polymerase II transcription by herpes simplex virus type 1.

Authors:  C A Spencer; M E Dahmus; S A Rice
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1.

Authors:  N S Markovitz; D Baunoch; B Roizman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture.

Authors:  J Chou; E R Kern; R J Whitley; B Roizman
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

5.  The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA-activated protein kinase.

Authors:  B He; M Gross; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

6.  Differential response of human cells to deletions and stop codons in the gamma(1)34.5 gene of herpes simplex virus.

Authors:  J Chou; A P Poon; J Johnson; B Roizman
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures.

Authors:  C A Bolovan; N M Sawtell; R L Thompson
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

9.  Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.

Authors:  S M Brown; J Harland; A R MacLean; J Podlech; J B Clements
Journal:  J Gen Virol       Date:  1994-09       Impact factor: 3.891

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  34 in total

1.  Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.

Authors:  Zachary M Parker; Aisling A Murphy; David A Leib
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

2.  The IE180 protein of pseudorabies virus suppresses phosphorylation of translation initiation factor eIF2α.

Authors:  N Van Opdenbosch; C Van den Broeke; N De Regge; E Tabarés; H W Favoreel
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Independent and cooperative antiviral actions of beta interferon and gamma interferon against herpes simplex virus replication in primary human fibroblasts.

Authors:  Tao Peng; Jia Zhu; Yon Hwangbo; Lawrence Corey; Roger E Bumgarner
Journal:  J Virol       Date:  2007-12-05       Impact factor: 5.103

4.  Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes.

Authors:  Karen E Johnson; Leela Chikoti; Bala Chandran
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

5.  Identification of replication-competent HSV-1 Cgal+ strain signaling targets in human hepatoma cells by functional organelle proteomics.

Authors:  Enrique Santamaría; María I Mora; Corinne Potel; Joaquín Fernández-Irigoyen; Elvira Carro-Roldán; Rubén Hernández-Alcoceba; Jesús Prieto; Alberto L Epstein; Fernando J Corrales
Journal:  Mol Cell Proteomics       Date:  2008-12-19       Impact factor: 5.911

6.  A limited innate immune response is induced by a replication-defective herpes simplex virus vector following delivery to the murine central nervous system.

Authors:  Zane Zeier; J Santiago Aguilar; Cecilia M Lopez; G B Devi-Rao; Zachary L Watson; Henry V Baker; Edward K Wagner; David C Bloom
Journal:  J Neurovirol       Date:  2009-09       Impact factor: 2.643

7.  Up to four distinct polypeptides are produced from the γ34.5 open reading frame of herpes simplex virus 2.

Authors:  Maria Korom; Katie L Davis; Lynda A Morrison
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

8.  Analysis of the role of autophagy in replication of herpes simplex virus in cell culture.

Authors:  Diane E Alexander; Stephen L Ward; Noboru Mizushima; Beth Levine; David A Leib
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

9.  Herpes simplex virus virion host shutoff attenuates establishment of the antiviral state.

Authors:  Tracy Jo Pasieka; Betty Lu; Seth D Crosby; Kristine M Wylie; Lynda A Morrison; Diane E Alexander; Vineet D Menachery; David A Leib
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

10.  Host responses to wild-type and attenuated herpes simplex virus infection in the absence of Stat1.

Authors:  Tracy Jo Pasieka; Cristian Cilloniz; Betty Lu; Thomas H Teal; Sean C Proll; Michael G Katze; David A Leib
Journal:  J Virol       Date:  2008-12-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.